Literature DB >> 33127624

Intraprostatic Tumor Segmentation on PSMA PET Images in Patients with Primary Prostate Cancer with a Convolutional Neural Network.

Dejan Kostyszyn1,2, Tobias Fechter1,3,4, Nico Bartl3,4, Anca L Grosu3,4, Christian Gratzke5, August Sigle5, Michael Mix6, Juri Ruf6, Thomas F Fassbender6, Selina Kiefer7, Alisa S Bettermann4, Nils H Nicolay3,4, Simon Spohn3,4, Maria U Kramer4, Peter Bronsert3,7, Hongqian Guo8, Xuefeng Qiu8, Feng Wang9, Christoph Henkenberens10, Rudolf A Werner11, Dimos Baltas1,3, Philipp T Meyer6, Thorsten Derlin11, Mengxia Chen8, Constantinos Zamboglou12,4.   

Abstract

Accurate delineation of the intraprostatic gross tumor volume (GTV) is a prerequisite for treatment approaches in patients with primary prostate cancer (PCa). Prostate-specific membrane antigen PET (PSMA PET) may outperform MRI in GTV detection. However, visual GTV delineation underlies interobserver heterogeneity and is time consuming. The aim of this study was to develop a convolutional neural network (CNN) for automated segmentation of intraprostatic tumor (GTV-CNN) in PSMA PET.
Methods: The CNN (3D U-Net) was trained on the 68Ga-PSMA PET images of 152 patients from 2 different institutions, and the training labels were generated manually using a validated technique. The CNN was tested on 2 independent internal (cohort 1: 68Ga-PSMA PET, n = 18 and cohort 2: 18F-PSMA PET, n = 19) and 1 external (cohort 3: 68Ga-PSMA PET, n = 20) test datasets. Accordance between manual contours and GTV-CNN was assessed with the Dice-Sørensen coefficient (DSC). Sensitivity and specificity were calculated for the 2 internal test datasets (cohort 1: n = 18, cohort 2: n = 11) using whole-mount histology.
Results: The median DSCs for cohorts 1-3 were 0.84 (range: 0.32-0.95), 0.81 (range: 0.28-0.93), and 0.83 (range: 0.32-0.93), respectively. Sensitivities and specificities for the GTV-CNN were comparable with manual expert contours: 0.98 and 0.76 (cohort 1) and 1 and 0.57 (cohort 2), respectively. Computation time was around 6 s for a standard dataset.
Conclusion: The application of a CNN for automated contouring of intraprostatic GTV in 68Ga-PSMA and 18F-PSMA PET images resulted in a high concordance with expert contours and in high sensitivities and specificities in comparison with histology as a reference. This robust, accurate and fast technique may be implemented for treatment concepts in primary prostate cancer. The trained model and the study's source code are available in an open source repository. COPYRIGHT
© 2021 by the Society of Nuclear Medicine and Molecular Imaging.

Entities:  

Keywords:  PSMA-PET; convolutional neuronal networks; histopathology; prostate cancer; segmentation

Mesh:

Substances:

Year:  2020        PMID: 33127624      PMCID: PMC8729869          DOI: 10.2967/jnumed.120.254623

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  26 in total

1.  Potential Impact of 68Ga-PSMA-11 PET/CT on the Planning of Definitive Radiation Therapy for Prostate Cancer.

Authors:  Jeremie Calais; Amar U Kishan; Minsong Cao; Wolfgang P Fendler; Matthias Eiber; Ken Herrmann; Francesco Ceci; Robert E Reiter; Matthew B Rettig; John V Hegde; Narek Shaverdian; Chris R King; Michael L Steinberg; Johannes Czernin; Nicholas G Nickols
Journal:  J Nucl Med       Date:  2018-04-13       Impact factor: 10.057

2.  Automatic Segmentation of the Prostate on CT Images Using Deep Neural Networks (DNN).

Authors:  Chang Liu; Stephen J Gardner; Ning Wen; Mohamed A Elshaikh; Farzan Siddiqui; Benjamin Movsas; Indrin J Chetty
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-03-16       Impact factor: 7.038

3.  Deep neural network for automatic characterization of lesions on 68Ga-PSMA-11 PET/CT.

Authors:  Yu Zhao; Andrei Gafita; Bernd Vollnberg; Giles Tetteh; Fabian Haupt; Ali Afshar-Oromieh; Bjoern Menze; Matthias Eiber; Axel Rominger; Kuangyu Shi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-12-07       Impact factor: 9.236

4.  Validation of different PSMA-PET/CT-based contouring techniques for intraprostatic tumor definition using histopathology as standard of reference.

Authors:  Constantinos Zamboglou; Thomas F Fassbender; Lina Steffan; Florian Schiller; Tobias Fechter; Montserrat Carles; Selina Kiefer; Hans C Rischke; Kathrin Reichel; Nina-Sophie Schmidt-Hegemann; Harun Ilhan; Alin F Chirindel; Guillaume Nicolas; Christoph Henkenberens; Thorsten Derlin; Peter Bronsert; Panayiotis Mavroidis; Ronald C Chen; Philipp T Meyer; Juri Ruf; Anca L Grosu
Journal:  Radiother Oncol       Date:  2019-08-17       Impact factor: 6.280

5.  Comparison of 68Ga-HBED-CC PSMA-PET/CT and multiparametric MRI for gross tumour volume detection in patients with primary prostate cancer based on slice by slice comparison with histopathology.

Authors:  Constantinos Zamboglou; Vanessa Drendel; Cordula A Jilg; Hans C Rischke; Teresa I Beck; Wolfgang Schultze-Seemann; Tobias Krauss; Michael Mix; Florian Schiller; Ulrich Wetterauer; Martin Werner; Mathias Langer; Michael Bock; Philipp T Meyer; Anca L Grosu
Journal:  Theranostics       Date:  2017-01-01       Impact factor: 11.556

6.  PSMA expression: a potential ally for the pathologist in prostate cancer diagnosis.

Authors:  Sara Bravaccini; Maurizio Puccetti; Martine Bocchini; Sara Ravaioli; Monica Celli; Emanuela Scarpi; Ugo De Giorgi; Maria Maddalena Tumedei; Giandomenico Raulli; Loredana Cardinale; Giovanni Paganelli
Journal:  Sci Rep       Date:  2018-03-09       Impact factor: 4.379

7.  Radiomic features from PSMA PET for non-invasive intraprostatic tumor discrimination and characterization in patients with intermediate- and high-risk prostate cancer - a comparison study with histology reference.

Authors:  Constantinos Zamboglou; Montserrat Carles; Tobias Fechter; Selina Kiefer; Kathrin Reichel; Thomas F Fassbender; Peter Bronsert; Goeran Koeber; Oliver Schilling; Juri Ruf; Martin Werner; Cordula A Jilg; Dimos Baltas; Michael Mix; Anca L Grosu
Journal:  Theranostics       Date:  2019-04-13       Impact factor: 11.556

Review 8.  Machine learning applications in prostate cancer magnetic resonance imaging.

Authors:  Renato Cuocolo; Maria Brunella Cipullo; Arnaldo Stanzione; Lorenzo Ugga; Valeria Romeo; Leonardo Radice; Arturo Brunetti; Massimo Imbriaco
Journal:  Eur Radiol Exp       Date:  2019-08-07

9.  Focal dose escalation for prostate cancer using 68Ga-HBED-CC PSMA PET/CT and MRI: a planning study based on histology reference.

Authors:  Constantinos Zamboglou; Benedikt Thomann; Khodor Koubar; Peter Bronsert; Tobias Krauss; Hans C Rischke; Ilias Sachpazidis; Vanessa Drendel; Nasr Salman; Kathrin Reichel; Cordula A Jilg; Martin Werner; Philipp T Meyer; Michael Bock; Dimos Baltas; Anca L Grosu
Journal:  Radiat Oncol       Date:  2018-05-02       Impact factor: 3.481

10.  Dosimetric Evaluation of PSMA PET-Delineated Dominant Intraprostatic Lesion Simultaneous Infield Boosts.

Authors:  Christopher D Goodman; Hatim Fakir; Stephen Pautler; Joseph Chin; Glenn S Bauman
Journal:  Adv Radiat Oncol       Date:  2019-09-27
View more
  11 in total

1.  A comprehensive prostate biopsy standardization system according to quantitative multiparametric MRI and PSA value: P.R.O.S.T score.

Authors:  Chao Liang; Yuhao Wang; Lei Ding; Meiling Bao; Gong Cheng; Pengfei Shao; Lixin Hua; Bianjiang Liu; Jie Li
Journal:  World J Urol       Date:  2022-07-22       Impact factor: 3.661

2.  A convolutional neural network for total tumor segmentation in [64Cu]Cu-DOTATATE PET/CT of patients with neuroendocrine neoplasms.

Authors:  Esben Andreas Carlsen; Kristian Lindholm; Andreas Kjaer; Flemming Littrup Andersen; Amalie Hindsholm; Mathias Gæde; Claes Nøhr Ladefoged; Mathias Loft; Camilla Bardram Johnbeck; Seppo Wang Langer; Peter Oturai; Ulrich Knigge
Journal:  EJNMMI Res       Date:  2022-05-28       Impact factor: 3.434

3.  Analytical performance of aPROMISE: automated anatomic contextualization, detection, and quantification of [18F]DCFPyL (PSMA) imaging for standardized reporting.

Authors:  Kerstin Johnsson; Johan Brynolfsson; Hannicka Sahlstedt; Nicholas G Nickols; Matthew Rettig; Stephan Probst; Michael J Morris; Anders Bjartell; Mathias Eiber; Aseem Anand
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-08-31       Impact factor: 10.057

4.  Feasibility of biology-guided radiotherapy using PSMA-PET to boost to dominant intraprostatic tumour.

Authors:  Mathieu Gaudreault; David Chang; Nicholas Hardcastle; Price Jackson; Tomas Kron; Michael S Hofman; Shankar Siva
Journal:  Clin Transl Radiat Oncol       Date:  2022-05-17

Review 5.  Incorporating PSMA-Targeting Theranostics Into Personalized Prostate Cancer Treatment: a Multidisciplinary Perspective.

Authors:  Thomas S C Ng; Xin Gao; Keyan Salari; Dimitar V Zlatev; Pedram Heidari; Sophia C Kamran
Journal:  Front Oncol       Date:  2021-07-28       Impact factor: 6.244

6.  Editorial: Exploring the Potential of PSMA-PET Imaging on Personalized Prostate Cancer Treatment.

Authors:  Harun Ilhan; Trevor Royce; Xuefeng Qiu; Constantinos Zamboglou
Journal:  Front Oncol       Date:  2022-02-02       Impact factor: 6.244

7.  Low-Dose 68 Ga-PSMA Prostate PET/MRI Imaging Using Deep Learning Based on MRI Priors.

Authors:  Fuquan Deng; Xiaoyuan Li; Fengjiao Yang; Hongwei Sun; Jianmin Yuan; Qiang He; Weifeng Xu; Yongfeng Yang; Dong Liang; Xin Liu; Greta S P Mok; Hairong Zheng; Zhanli Hu
Journal:  Front Oncol       Date:  2022-01-26       Impact factor: 6.244

8.  Urethra Sparing With Target Motion Mitigation in Dose-Escalated Extreme Hypofractionated Prostate Cancer Radiotherapy: 7-Year Results From a Phase II Study.

Authors:  Carlo Greco; Oriol Pares; Nuno Pimentel; Vasco Louro; Beatriz Nunes; Justyna Kociolek; Joep Stroom; Sandra Vieira; Dalila Mateus; Maria Joao Cardoso; Ana Soares; Joao Marques; Elda Freitas; Graça Coelho; Zvi Fuks
Journal:  Front Oncol       Date:  2022-03-29       Impact factor: 5.738

Review 9.  Value of PET imaging for radiation therapy.

Authors:  Constantin Lapa; Ursula Nestle; Nathalie L Albert; Christian Baues; Ambros Beer; Andreas Buck; Volker Budach; Rebecca Bütof; Stephanie E Combs; Thorsten Derlin; Matthias Eiber; Wolfgang P Fendler; Christian Furth; Cihan Gani; Eleni Gkika; Anca-L Grosu; Christoph Henkenberens; Harun Ilhan; Steffen Löck; Simone Marnitz-Schulze; Matthias Miederer; Michael Mix; Nils H Nicolay; Maximilian Niyazi; Christoph Pöttgen; Claus M Rödel; Imke Schatka; Sarah M Schwarzenboeck; Andrei S Todica; Wolfgang Weber; Simone Wegen; Thomas Wiegel; Constantinos Zamboglou; Daniel Zips; Klaus Zöphel; Sebastian Zschaeck; Daniela Thorwarth; Esther G C Troost
Journal:  Strahlenther Onkol       Date:  2021-07-14       Impact factor: 3.621

Review 10.  Radiomics in prostate cancer imaging for a personalized treatment approach - current aspects of methodology and a systematic review on validated studies.

Authors:  Simon K B Spohn; Alisa S Bettermann; Fabian Bamberg; Matthias Benndorf; Michael Mix; Nils H Nicolay; Tobias Fechter; Tobias Hölscher; Radu Grosu; Arturo Chiti; Anca L Grosu; Constantinos Zamboglou
Journal:  Theranostics       Date:  2021-07-06       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.